Charles River Laboratorie... (CRL)
Charles River Laboratories International Inc. (CRL) Stock Price, Analysis & Data
No hay datos disponibles
| Precio de compra | 291.71 |
| Capitalización de mercado | 14.04B |
| Ingresos (TTM) | 4B |
| Beneficio neto (TTM) | -238.46M |
| Beta | 1.38 |
| EPS (TTM) | -4.81 |
| Ratio PER (TTM) | n/a |
| Adelante PE | 22.97 |
| P/B (TTM) | 4.90 |
| P/S (TTM) | 3.48 |
| Earnings Date | Nov 4, 2026 |
| Precio de venta | 293.01 |
| Volumen | 942,048 |
| Volumen medio (20D) | 896,422 |
| Abierto | 285.72 |
| Anterior Cerrar | 290.00 |
| Rango del día | 281.73 - 299.32 |
| Rango de 52 semanas | 144.26 - 299.32 |
| analista | n/a |
| Precio objetivo | n/a |
| Dividendos | n/a |
| Fecha ex dividendo | n/a |
Acerca de CRL
Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. The Research Models and Services segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research a...
Desempeño financiero
En 2025, los ingresos de Charles River Laboratories International fueron 4.02B, una disminución de -0.85% en comparación con 4.05B del año anterior. Las ganancias fueron -144.34M, una disminución de -1,501.75%.
Estados financierosSorpresa de resultados
Los analistas proyectan ingresos de ... Actualizar
12 horas hace · The Wall Street Journal
How an Insider CEO Is Taking a Fresh Look at Charles River“I want to roll out my strategy to them so that they know why we’re doing things, why the urgency, what are we trying to accomplish and really what it means to them,” Girshick told me during a recent ...
